Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |